AArtificial intelligence Read More Big Tech is paying for the AI boom, and chipmakers are cashing in: Chart of the DayJuly 11, 2026 Wall Street knows Big Tech can spend on artificial intelligence. The harder question is how quickly that spending…
EEconomy Read More Apollo’s Sløk: The market faces big risks if hyperscalers’ AI profits get delayedJuly 10, 2026 Wall Street expects hyperscaler companies’ free cash flow to boom, starting in 2028. If that boom doesn’t materialize,…
PPersonal finance Read More This 7% Yielding Healthcare Powerhouse Belongs in Retirees’ PortfoliosJune 30, 2026 Quick Read PFE’s 7.27% yield looks safe on a 53% adjusted payout ratio, but free cash flow fell…
GGadgets Read More 2 Reasons to Watch IONQ and 1 to Stay CautiousJune 23, 2026 Since December 2025, IonQ has been in a holding pattern, posting a small return of 4% while floating…
MMobile Read More 3 Reasons We’re Fans of AppLovin (APP)June 21, 2026 AppLovin’s stock price has taken a beating over the past six months, shedding 26.6% of its value and…
HHealthcare Read More 2 Healthcare Stocks with Exciting Potential and 1 Facing ChallengesMay 29, 2026 Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has…
HHealthcare Read More 2 Healthcare Stocks Worth Investigating and 1 Facing HeadwindsMay 22, 2026 Personal health and wellness is one of the many secular tailwinds for healthcare companies. But speed bumps such…
MMedication Read More Is It Too Late To Consider Revolution Medicines (RVMD) After A 240% One Year Surge?May 11, 2026 Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million…
NNutrition Read More Is It Too Late To Consider ImmunityBio (IBRX) After The Recent 181% Monthly Surge?February 11, 2026 Make better investment decisions with Simply Wall St’s easy, visual tools that give you a competitive edge. If…
UUnited Kingdom Read More Undiscovered Gems in the United Kingdom to Explore This January 2026January 13, 2026 The United Kingdom’s market landscape is currently navigating challenges, as evidenced by the recent declines in the FTSE…
MMedication Read More Is It Too Late To Consider Revolution Medicines (RVMD) After Its Recent 50% Weekly Surge?January 11, 2026 If you are wondering whether Revolution Medicines is still worth considering after its recent run, this article will…
SSpace Read More Is It Too Late To Consider AST SpaceMobile (ASTS) After Its 324% One Year Surge?January 7, 2026 If you are wondering whether AST SpaceMobile’s current share price reflects its true worth, you are not alone.…